Long-Term Clinical Results with the Implantable Defibrillator
Autor: | R. Lewis, E. P. Veltri, Lawrence S.C. Griffith, G. Tomaselli, T. Guarnieri, J. M. Juanteguy, L. Watkins |
---|---|
Rok vydání: | 1992 |
Předmět: |
medicine.medical_specialty
Heart disease Ventricular Tachyarrhythmias business.industry medicine.medical_treatment Cardiomyopathy Implantable defibrillator medicine.disease Implantable cardioverter-defibrillator Sudden cardiac death Internal medicine cardiovascular system Etiology medicine Cardiology Myocardial infarction business |
Zdroj: | The Implantable Cardioverter/Defibrillator ISBN: 9783642765773 |
DOI: | 10.1007/978-3-642-76575-9_10 |
Popis: | Sudden cardiac death is the leading cause of cardiac mortality in patients with heart disease. Approximately 400000 such deaths occur in the United States alone each year [1], It has been established that the vast majority of sudden cardiac deaths are due to ventricular tachyarrhythmias, with only approximately 20% of such cases due to identifiable etiology such as acute myocardial infarction [2, 3]. Tragically, when out-of-hospital cardiac arrest occurs, only one of five individuals will survive to hospital discharge. Those patients at high risk for sudden cardiac death are survivors of out-of-hospital cardiac arrest without identifiable causes and patients with recurrent ventricular tachycardia with underlying heart disease, particularly those with remote myocardial infarction with associated poor left ventricular function and those with cardiomyopathy. In such patients, the automatic implantable cardioverter defibrillator (AICD) has been the landmark breakthrough in therapy [4]. |
Databáze: | OpenAIRE |
Externí odkaz: |